Tag Archives: innovation

Notch Therapeutics Strengthens Leadership Team with Appointment of Kamran Alam as CFO and Gregory Block as SVP, Corporate Development – BioSpace

TORONTO, Oct. 19, 2020 /PRNewswire/ --Notch Therapeutics Inc., a cell therapy company with a proprietary platform for generating renewable stem cell-derived T cell therapies for cancer and other immune disorders, announced today the appointment of Kamran Alam as Executive Vice President, Finance and Chief Financial Officer and Gregory Block as Senior Vice President, Corporate Development, effective immediately.

"Adding these experienced leaders to our team underpins our strategy of advancing our pipeline and supporting our partnering initiatives," said David Main, President and Chief Executive Officer of Notch. "Their combined expertise in financial and corporate strategy will augment our deep technical team as we advance our proprietary platform that enables the development of highly consistent T cell therapies manufactured at industrial scale and lower cost. We look forward to their contributions as members of our executive team."

Kamran Alam, Executive Vice President, Finance and Chief Financial OfficerKamran Alam brings to Notch more than 20 years of global corporate finance and business development leadership experience. He joins Notch from Neoleukin Therapeutics, where he served as Interim Chief Financial Officer following Neoleukin's merger in 2018 with Aquinox Pharmaceuticals. Previously, in his role as Chief Financial Officer and Vice President, Finance at Aquinox, Mr. Alam provided finance leadership for the company's IPO on the NASDAQ stock exchange in 2014. Prior to his tenure with Aquinox, Mr. Alam held senior roles in business development for a number of biotechnology and pharmaceutical companies. Mr. Alam is a Chartered Professional Accountant. He holds a B.Sc. in Cell Biology and Genetics from the University of British Columbia and an M.B.A. in International Business and Strategy from the University of Victoria.

Gregory Block, Ph.D., Senior Vice President, Corporate DevelopmentGregory Block is a seasoned biotechnology executive with more than 10 years of experience in the development and commercialization of novel therapeutic modalities. Prior to his position with Notch, he served as Director of Business Development for Astellas Pharmaceuticals, where he led business development and strategic initiatives for regenerative medicine and cell therapy immune oncology. Dr. Block joined Astellas via the company's 2018 acquisition of Universal Cells Inc., where he was instrumental in company-building and business development. Dr. Block holds a Ph.D. in Molecular Biology from Tulane University and completed a fellowship at the University of Washington.

About Notch Therapeutics (www.notchtx.com)Notch Therapeutics is a cell therapy company that has unlocked the ability to produce T cells and other cells from any source of stem cells. At the core of the Notch technology is the Engineered Thymic Niche (ETN) platform, which enables precision control of cell fate during the differentiation and expansion of stem cells. The ETN is the first technology that can reliably generate T-cells from iPSC-derived progenitor cells using fully defined, non-xenogenic reagents at industrial scale. By leveraging the ETN platform, Notch is positioned to design and deliver the next generation of T cell therapeutics that are specifically engineered to address the underlying biology of complex disease systems. The technology was invented in the laboratories of Juan-Carlos Ziga-Pflcker, Ph.D. at Sunnybrook Research Institute and Peter Zandstra, Ph.D., FRSC at the University of Toronto. Notch was founded by these two institutions, in conjunction with MaRS Innovation (now Toronto Innovation Acceleration Partners) and the Centre for Commercialization of Regenerative Medicine (CCRM) in Toronto.

Contact:Mary MoynihanM2Friend Biocommunications802-951-9600mary@m2friend.com

View original content:http://www.prnewswire.com/news-releases/notch-therapeutics-strengthens-leadership-team-with-appointment-of-kamran-alam-as-cfo-and-gregory-block-as-svp-corporate-development-301154463.html

SOURCE Notch Therapeutics

Read the original post:
Notch Therapeutics Strengthens Leadership Team with Appointment of Kamran Alam as CFO and Gregory Block as SVP, Corporate Development - BioSpace

Notch Therapeutics Strengthens Leadership Team with Appointment of Kamran Alam as CFO and Gregory Block as SVP, Corporate Development – PRNewswire

TORONTO, Oct. 19, 2020 /PRNewswire/ --Notch Therapeutics Inc., a cell therapy company with a proprietary platform for generating renewable stem cell-derived T cell therapies for cancer and other immune disorders, announced today the appointment of Kamran Alam as Executive Vice President, Finance and Chief Financial Officer and Gregory Block as Senior Vice President, Corporate Development, effective immediately.

"Adding these experienced leaders to our team underpins our strategy of advancing our pipeline and supporting our partnering initiatives," said David Main, President and Chief Executive Officer of Notch. "Their combined expertise in financial and corporate strategy will augment our deep technical team as we advance our proprietary platform that enables the development of highly consistent T cell therapies manufactured at industrial scale and lower cost. We look forward to their contributions as members of our executive team."

Kamran Alam, Executive Vice President, Finance and Chief Financial OfficerKamran Alam brings to Notch more than 20 years of global corporate finance and business development leadership experience. He joins Notch from Neoleukin Therapeutics, where he served as Interim Chief Financial Officer following Neoleukin's merger in 2018 with Aquinox Pharmaceuticals. Previously, in his role as Chief Financial Officer and Vice President, Finance at Aquinox, Mr. Alam provided finance leadership for the company's IPO on the NASDAQ stock exchange in 2014. Prior to his tenure with Aquinox, Mr. Alam held senior roles in business development for a number of biotechnology and pharmaceutical companies. Mr. Alam is a Chartered Professional Accountant. He holds a B.Sc. in Cell Biology and Genetics from the University of British Columbia and an M.B.A. in International Business and Strategy from the University of Victoria.

Gregory Block, Ph.D., Senior Vice President, Corporate DevelopmentGregory Block is a seasoned biotechnology executive with more than 10 years of experience in the development and commercialization of novel therapeutic modalities. Prior to his position with Notch, he served as Director of Business Development for Astellas Pharmaceuticals, where he led business development and strategic initiatives for regenerative medicine and cell therapy immune oncology. Dr. Block joined Astellas via the company's 2018 acquisition of Universal Cells Inc., where he was instrumental in company-building and business development. Dr. Block holds a Ph.D. in Molecular Biology from Tulane University and completed a fellowship at the University of Washington.

About Notch Therapeutics (www.notchtx.com)Notch Therapeutics is a cell therapy company that has unlocked the ability to produce T cells and other cells from any source of stem cells. At the core of the Notch technology is the Engineered Thymic Niche (ETN) platform, which enables precision control of cell fate during the differentiation and expansion of stem cells. The ETN is the first technology that can reliably generate T-cells from iPSC-derived progenitor cells using fully defined, non-xenogenic reagents at industrial scale. By leveraging the ETN platform, Notch is positioned to design and deliver the next generation of T cell therapeutics that are specifically engineered to address the underlying biology of complex disease systems. The technology was invented in the laboratories of Juan-Carlos Ziga-Pflcker, Ph.D. at Sunnybrook Research Institute and Peter Zandstra, Ph.D., FRSC at the University of Toronto. Notch was founded by these two institutions, in conjunction with MaRS Innovation (now Toronto Innovation Acceleration Partners) and the Centre for Commercialization of Regenerative Medicine (CCRM) in Toronto.

Contact:Mary MoynihanM2Friend Biocommunications802-951-9600[emailprotected]

SOURCE Notch Therapeutics

Follow this link:
Notch Therapeutics Strengthens Leadership Team with Appointment of Kamran Alam as CFO and Gregory Block as SVP, Corporate Development - PRNewswire

October: flf-award | News and features – University of Bristol

Four Bristol researchers have been awarded UK Research and Innovation's (UKRI) prestigious Future Leaders Fellowships. The awards, designed to establish the careers of world-class research and innovation leaders across the UK to help them tackle major global challenges, are announced today [15 October] by Science Minister Amanda Solloway.

The initiative will see 101 fellows based at UK universities and businesses supported through an investment of 109 million.

Announcing the successful fellows at todays Future Leaders Conference, Science Minister Amanda Solloway said: We are committed to building back better through research and innovation, and supporting our science superstars in every corner of the UK. By backing these inspirational Future Leaders Fellows, we will ensure that their brilliant ideas can be transferred straight from the lab into vital everyday products and services that will help to change all our lives for the better.

UK Research and Innovation Chief Executive, Professor Dame Ottoline Leyser, said: Future Leaders Fellowships provide researchers and innovators with freedom and support to drive forward transformative new ideas and the opportunity to learn from peers right across the country.

"The fellows announced today illustrate how the UK continues to support and attract talented researchers and innovators across every discipline to our universities and businesses, with the potential to deliver change that can be felt across society and the economy."

Four Bristol researchers are among the recipients of UKRI Future Leaders Fellowships. These include:

Dr Hannah Griffiths from Bristols School of Biological Sciences who will explore how large above-ground mammals, such as deer, as well as tiny invertebrates and microbes under the soil, impact forest growth providing new knowledge that will inform efforts to increase biodiversity and combat climate change.

Soil communities are extremely complex and diverse, with millions of species and billions of individuals living within a single ecosystem. However, because life in soil is so small and numerous, studying below-ground food webs is extremely challenging and time consuming. Therefore, an important outcome of this work will be the use of cutting-edge genetic sequencing techniques to determine, for the first time, how the diversity of these difficult to study organisms influences carbon sequestration and therefore climate change mitigation strategies. The study will help us understand and mitigate the consequences of declines in global biodiversity for the ecosystem services that support humanity and generate data that will help manage the restoration of forests to reverse the decline in biodiversity and help mitigate global warming.

Dr Anya Skatova, a Turing Fellow and behavioural scientist at Bristol Medical School (Population Health Sciences) will work on realising the value of transaction data to improve population health. Her fellowship will question whether shopping history data, such as recorded through supermarket loyalty cards, can be used in a positive way to support health research and the development of new interventions. Dr Skatova, who is currently based in Bristols School of Psychological Science, will link retail loyalty card datasets with rich medical, genetic, early life environment and other records collected by the Avon Longitudinal Study of Parents and Children (ALSPAC). This will allow to create a transaction data linkage framework for other longitudinal cohorts and population health more broadly. Further, the fellowship will establish the feasibility of novel ways of assessing both health outcomes and associated lifestyle choices through objective measures of real-world behaviours reflected in retail shopping history data,and apply new methods on reproductive health domain.

The ultimate goal of the study is to put large commercial datasets such as shopping history data at the service of the public healthcare through contributing to early detection of diseases, developing and testing targeted interventions, and contributing to the evidence-based healthcare and health research.

Dr Siddhartha Kar, a cancer epidemiologist at the Bristol Medical School will study how a wide range of everyday factors, such as exercise and diet, as well as the human bodys physiology and biochemistry relate to the molecular characteristics of tumours in cancer patients. Dr Kar will then map how these tumour molecular characteristics, in turn, affect survival after a diagnosis of cancer. Some of these everyday factors, particularly those associated with lifestyle, are modifiable through public health interventions. Other physiological and biochemical measures, such as the levels of specific proteins or cholesterol in the blood, and the tumour molecular characteristics themselves, may be amenable to medical treatment. By establishing the causal chain from these factors or measures to tumour molecular features to cancer progression, Dr Kars work will inform the development of novel approaches to cancer prevention and therapy.

Dr Joshua Silverstone, a Leverhulme Early Career Fellow and member of the Quantum Engineering Technology (QET) Labs in the Department of Electrical and Electronic Engineering will develop the optical-electrical systems that are essential for realising the coming quantum revolution. The development of quantum technologies will change how we collect, compute, and communicate information in our everyday lives. Using long-wavelength single photons, particles of light, together with tightly integrated electronics, Dr Silverstone and his team hope to overcome the barriers to building big quantum technology, making it useful in the wider world.

UKRIs initiative aims to support the creation of a new cohort of research and innovation leaders who will have links across different sectors and disciplines. Awardees will each receive between 400,000 and 1.5 million over an initial four years. The grant supports challenging and novel projects, and the development of the fellows career. The funding can also used to support team members, their development, and pay for equipment and other needs.

The Future Leaders Fellowships scheme, which is run by UK Research and Innovation, will recognise up to 550 individuals with a total investment of 900 million committed over 3 years. The scheme helps universities and businesses in the UK recruit, develop and retain the worlds best researchers and innovators, regardless of their background. They can apply for up to 1.5 million to support the research and innovation leaders of the future, keeping the UK at the cutting edge of innovation. Each fellowship will last four to seven years.

Round six of the Future Leaders Fellowships is currently open to applications. See: http://www.ukri.org/funding/funding-opportunities/future-leaders-fellowships/how-to-apply/

Read the original here:
October: flf-award | News and features - University of Bristol

Early development of the Neanderthal ribcage reveals a different body shape at birth compared to modern humans – Science Advances

Abstract

Ontogenetic studies provide clues for understanding important paleobiological aspects of extinct species. When compared to that of modern humans, the adult Neanderthal thorax was shorter, deeper, and wider. This is related to the wide Neanderthal body and is consistent with their hypothetical large requirements for energy and oxygen. Whether these differences were already established at birth or appeared later during development is unknown. To delve into this question, we use virtual reconstruction tools and geometric morphometrics to recover the 3D morphology of the ribcages of four Neanderthal individuals from birth to around 3 years old: Mezmaiskaya 1, Le Moustier 2, Dederiyeh 1, and Roc de Marsal. Our results indicate that the comparatively deep and short ribcage of the Neanderthals was already present at birth, as were other skeletal species-specific traits. This morphology possibly represents the plesiomorphic condition shared with Homo erectus, and it is likely linked to large energetic requirements.

Prenatal and early postnatal growth and development are crucial to understanding the adult size and shape of the different anatomical regions because of the large number and high rate of size and shape changes occurring in the human body during those phases (15). Also, from an evolutionary point of view, prenatal and early postnatal ontogeny are decisive because evolution happens via phylogenetic modification of the ontogenetic processes that occur mostly in those phases (3, 6, 7).

Adult morphologies can vary because of interspecific differences in the shape of an anatomical element at the moment of birth that are caused by differences in the prenatal ontogenetic trajectories or because of differences in the shape of an anatomical element that arise after birth that are caused by differences in the postnatal ontogenetic trajectories, either concerning their orientations, lengths, or a combination of both (1). Roughly speaking, if morphological differences are found at birth and the postnatal ontogenetic pattern is equal in the two species, their ontogenetic trajectories will be parallel. Conversely, if they have a similar morphology at birth but show differences in the postnatal ontogenetic pattern, their ontogenetic trajectories will be divergent (13). This distinction is important because parallel postnatal ontogenetic trajectories between two closely related species could point to a consistency of genetic regulation of that anatomical element (1). In addition, the fact that a morphological feature is already present at birth will suggest that it is a relevant taxonomical characteristic not caused by developmental plasticity.

Despite genetic similarities that allowed for admixture (8), there is a well-established consensus that Neanderthals showed significant morphological differences when compared to modern humans (MHs) in the cranium and postcranium (9, 10). Some of these differences are plesiomorphic inherited traits from their Early or Middle Pleistocene ancestors, while others are present exclusively in Neanderthals (autapomorphies) (11, 12). Neanderthals were highly encephalized (4, 13, 14) and heavy-bodied hominins (15, 16) requiring large amounts of energy (1719). It has been proposed that to fulfill these energetic demands, the Neanderthal thorax had a large estimated total lung capacity (19) and a different thoracic shape that included a shorter, slightly deeper, and mediolaterally larger chest with more horizontally oriented ribs and a more invaginated thoracic spine, compared to MH (1926).

The very specific Neanderthal traits found throughout the skeleton (i.e., those different in size and shape from MH) are the result of differences present at birth and/or differences in the postnatal ontogenetic pattern, which may vary in different skeletal regions. However, despite being the best-known extinct human species, there are only a few studies on the Neanderthal postnatal ontogeny due to the paucity of well-preserved subadult fossil remains, especially of the postcranium. Nonetheless, despite the limited record, some patterns have been proposed, providing evolutionary insights. For example, MH and Neanderthal femoral length followed similar growth patterns with no differences at birth (27). Other anatomical traits (e.g., general cranium shape, clavicle length, and femoral and tibial robusticity) seemed to be different at birth between the two species and followed parallel ontogenetic trajectories, resulting in different adult shapes (2, 27, 28). Last, in the case of the mandible (2, 29) and the brain (4, 13, 14), Neanderthals and MH had not only different shapes at birth but also divergent growth patterns. However, there are still many anatomical regions that are relatively well known in the Neanderthal adult record for which there are few ontogenetic studies, which is the case of the thorax (24, 25). Methodological improvements in virtual reconstruction and statistical missing data estimation have improved the knowledge of the adult Neanderthal thorax (26). However, ribs and vertebrae from perinates and infants are smaller and more fragile, which represents a major challenge during the study of the early postnatal ontogeny of the Neanderthal thorax. So far, only basic descriptions and inventories of fossil ribs and vertebrae have been available (30, 31), and artistic license was used when ribcage reconstructions of subadults were made (4).

Apart from this very basic knowledge, the little information we have about this issue comes from (i) descriptive anatomy of the prenatal (32) and early postnatal ontogeny of MH (33, 34) and (ii) late postnatal ontogeny of the Neanderthal first ribs (20). Research on prenatal ontogeny of the MH ribcage has found that all thoracic dimensions (anteroposterior, craniocaudal, and mediolateral) are modified during the fetal period to result in the newborn ribcage (32). All these dimensions develop differently in the different rib levels: For example, all levels have roughly the same anteroposterior relative length in early fetuses, whereas the upper and central ribs of late fetuses are much deeper, relatively, than the lower levels (32). This is consistent with research on later postnatal ontogeny of the human ribcage, which has found that, after birth, the upper and lower thorax have a differential development that gives rise to the adult ribcage of MH, which is relatively expanded in the cranial part and narrow in the caudal part (33, 34). This differential development, controlled by Hox gene expression (35), is crucial because it indicates that slight modifications during development at different rib levels would cause different ribcage morphologies. This could have evolutionary implications for understanding the adult thorax not only in our own species but also in other hominins such as Neanderthals. In addition, the only study that tackled the postnatal ontogeny of the thoracic skeleton in this species was carried out by Bastir et al. (20). They found divergent ontogenetic trajectories in the first ribs of MH and Neanderthals, the latter showing less curved first ribs in the youngest specimen (La Ferrassie 6) and along the entire postnatal ontogeny when compared to MH. However, we do not know to what extent this could be extrapolated to the entire thorax.

In this study, we used virtual and statistical methods to reconstruct the ribcage of four young Neanderthal specimens (Table 1), identifying potential differences with MH in thorax morphology affecting the evolution of body shape and influencing respiration. Specifically, we reconstructed the ribcages of perinatal individuals of Mezmaiskaya 1 [M1; 7 to 14 days (4)] and Le Moustier 2 [LM2; <120 days (36)] and infant individuals from Dederiyeh 1 [D1; 1.41 years (37)] and Roc de Marsal (RdM; 2.54 years (31)]. We also provided the first three-dimensional (3D) morphological assessment of the early postnatal ontogeny of the MH ribcage during the decisive first 3 years of postnatal life to serve as a comparative baseline. Because of the differences in this anatomical region in adults, we tested whether Neanderthal thorax morphology was already different from that of MH at birth.

Final reconstructions of the four Neanderthal ribcages are shown in Fig. 1 and text S1.

Bones that are preserved in the original specimen are shown in red, whereas mirror images are shown in blue and statistical estimations in gray (only for D1 specimen).

The ribcage of MH shows a rapid growth during the first ca. 100 days of life, which changes to a slower growth rate afterward (Fig. 2). For Neanderthals, we measured the centroid size (CS; see Materials and Methods) directly from the thorax reconstruction in D1 and using the costal size and thorax CS correlation (double-checked in the latter 3D reconstruction) in the rest of the individuals (Table 1 and text S1). When plotted with respect to their estimated age (or age ranges), the perinatal M1 individual fits well within MH size variation; the infant D1 is within this variation but above the MH regression line. For the two other Neanderthals, their current age-at-death ranges are wide but consistent with growth patterns observed for M1 and D1. The growth trajectory based on the mean Neanderthal age-at-death estimates roughly overlaps with that of MH during the first ca. 100 days but then diverges, with the Neanderthals growth being slightly faster. This overall pattern, using CS as a proxy for thoracic size, is also present on the tubercle-ventral chord (TVC) of individual ribs (text S2), a classic measurement for evaluating costal size (22, 25).

For the latter, we plotted minimum (triangles), average (squares), and maximum (circles) ages proposed in the literature. The growth trajectories of MH and Neanderthals are displayed in blue and red color, respectively, and Neanderthal trajectories representing minimum and maximum ages are displayed as dotted lines. Note that individuals with very similar CS are overlapped, e.g., the case of Ind27 and Ind29.

When compared to MH of the same CS (as a proxy of volume), the four Neanderthal reconstructions showed metric differences that were consistent in all of them regardless of their age at death (text S3). All the Neanderthals had a craniocaudally shorter thoracic spine and a deeper thorax anterior-posteriorly when compared to MH of equivalent CS. However, the thorax width of the Neanderthals exceeded that of MH only in the oldest individuals (D1 and RdM), but not in the youngest ones (M1 and LM2; Table 2 and text S3).

Thorax width was quantified at the level of rib 7, thorax depth is at the level of T5 from the spinous process to the distal end of rib 5 (average of both sides), and anterior spine length is quantified as the distance between the anterior-superiormost point of T1 body and the anterior-inferiormost point of the T12 body. Standardized values of MHs were calculated on the basis of linear regression of classic measurements on full thorax CS (text S4). Smaller Neanderthal values are labeled with the symbol *, whereas larger values are labeled by the symbol #.

During early postnatal ontogeny, MH changes from a ribcage that is relatively narrow in the cranial part and extremely wide in the caudal part toward a ribcage that is volumetrically expanded in the cranial part and still wide in the caudal part (text S4). Perinatal Neanderthals (M1 and LM2) also have an upper ribcage that is relatively narrower than in older specimens (D1 and RdM), who have a more globular ribcage with similar widths at the upper and lower thorax (Fig. 1). In addition, the exploration of the 3D warps associated with standardized CS in Neanderthals and MH shows consistent interspecific morphological differences throughout the postnatal ontogeny studied here (Fig. 3). The Neanderthal thoracic spine is relatively shorter, and from the third rib onward, the ribcage of the Neanderthals is relatively deeper than in MH. In the most complete individual (D1), it is also possible to observe that its spine is more invaginated within the thorax than in MH (text S5). In this individual, the mid-lower ribs are relatively longer than the uppermost and lowermost ones, when compared to MH of the same CS.

To better visualize the morphological differences between species, we warped a complete MH infant thorax 3D model into the coordinates of the fossil specimens using EVAN Toolbox software. Human standardizations were calculated using a multivariate regression of shape on the size of the 29 individuals from the comparative human sample. Perinatal Neanderthals (M1 and LM2) have an upper ribcage that is relatively narrower than in older specimens (D1 and RdM), who have a more globular ribcage, with similar widths at the upper and lower thorax (Fig. 1). Besides, the Neanderthal thoracic spine is relatively shorter, and from the third rib onward, the ribcage of the Neanderthals is relatively deeper than in MH. In the most complete individual (D1), it is possible to observe that this spine is more invaginated into the thorax than in MH. In this individual, it is also possible to assess that, when compared to MH of the same CS, the mid-lower ribs are relatively larger than the uppermost and lowermost ones. Regarding the orientation of the ribs in the sagittal plane, different declination can be observed at different rib levels, with the upper Neanderthal ribs (from 1st to 6th) more declined than in MH and the lower ribs (from 10th to 12th) more horizontally oriented. Rib torsion also contributes to interspecific differences because Neanderthal central ribs (from 6th to 8th) of early individuals have a stronger torsion (understood as spiraling) than in MH.

Regarding the orientation of the ribs in the sagittal plane, a different declination can be observed at different rib levels, with the upper Neanderthal ribs (from 1st to 6th) being more declined than in MH and the lower ribs (from 10th to 12th) more horizontally oriented. Rib torsion also contributes to interspecific differences because Neanderthal central ribs (from 6th to 8th) of early individuals have a stronger torsion (understood as spiraling along the rib axis) than in MH. Last, other minor differences can also be observed in Fig. 3. For example, both the upper (from 1st to 5th) and very lower (from 10th to 12th) regions of the Neanderthal ribcage are slightly wider than in MH, and their first ribs are less curved than in MH (see details in text S5).

When the morphological ontogenetic variation between species is explored in a Procrustes form space (size + shape; see Materials and Methods) principal components analysis (PCA; Fig. 4), we observe that the PC1 versus PC2 projection (96.57% of the variance of the sample) captures ontogenetic variation along the first PC and interspecific variation along the second PC. During postnatal ontogeny (from the PC1 negative values to the positive ones), the pear-shaped ribcage of newborns changes into a more globular ribcage in infancy. The main changes, which occur in the upper ribcage, are likely related to changes in the rib orientation at the costovertebral joint and the ossification at the distal end of the ribs. The morphological variation between humans and Neanderthals (observed along PC2 and independent of ontogenetic state) shows that the latter present more caudally oriented ribs and spines that are shorter and more invaginated within the thorax than in MH. Last, the relative maximum depth is found in the central-upper thorax in MH, whereas in Neanderthals it is found in the central-lower thorax.

PC1 represents mainly ontogeny, whereas PC2 represents interspecific variation.

This clear ontogenetic and interspecific distribution along PC1 and PC2 allows us to evaluate a hypothetical ontogenetic linear regression for each species, which is almost parallel between humans and Neanderthals during early postnatal ontogeny. The slope of the Neanderthal linear regression (a = 0.008) is clearly within the confidence interval (CI) for their regression slope (a = 0.031; CI, 0.065 to 0.032). This implies that although Neanderthals and MH are different at birth, the morphological trend is similar in both species during early ontogeny, with each species undergoing a volumetric expansion of the ribcage and a lower thorax still relatively wider than the upper one but to a much lesser degree than in adults.

Most authors agree that prenatal ontogeny and the first years of postnatal ontogeny are key to understanding species-specific features of hominin anatomy that we find in adults because of the prominent growth and development during those phases (1, 35, 29). Our results allow us to explore this issue in the Neanderthal ribcage, shed light on their body shape evolution and bioenergetics, and have implications for understanding the evolution of the thorax in MH.

Previous research on Neanderthal adult thorax size found that the upper Neanderthal ribs were similar (25) or even smaller than in MH (20, 24), whereas the central-lower ribs were significantly larger (22, 24, 25). While the Neanderthal costal skeleton as a whole was large, relative to the humeral length (25), the general volume (using CS as a proxy) was similar to MH due to both the shorter thoracic spine and the morphology resulting from the articulation of the costal skeleton with the spine (24, 26).

In general terms, and when compared to MH, our study shows that Neanderthals had similar general thorax sizes around birth but reached slightly larger thorax sizes in infancy (D1 and RdM), suggesting a higher thorax growth rate during the first few years of postnatal life. This would be consistent with the notion of a more rapid life history for Neanderthals based on evidence of dental histology (3840) and also dental development in individual D1, thought to be a 2-year-old because of the development of their incisors (41) despite the estimated histological age at death of ca. 1 year and 5 to 7 months (37). On one hand, we can hypothesize that because the overall adult Neanderthal ribcage was similar to that in MHs, if this rapid growth rate was not limited only to the early postnatal ontogeny and occurred later, the adult size in Neanderthal thoraces would have been reached earlier than in MH. On the other hand, other researchers have proposed that juvenile Neanderthals had a slower fusion of some elements of the thoracic spine compared to MH (27), which could suggest a slowdown of the thoracic growth or a dissociation of the ribcage size increase and the fusion of some spinal elements in Neanderthals. Dissociations of dental development, somatic growth, and life history variables are not infrequent (42), and a more comprehensive approach would include the study of the dental development along with the development of other anatomical elements such as the ribcage or the brain from the same individuals.

In our study, we built a growth trajectory based on the studied individuals (Fig. 2) using an accurate age-at-death estimate for M1 and D1 individuals and a relatively large range for LM2 and RdM. For these individuals, we have used the mean value of the upper and lower limits of the age range. In the case of RdM, the value used (1186 days; i.e., 3.24 years) was similar to the estimated histological age of Engis [3 years (39)], which shows a similar pattern of development to RdM (43). In addition, on the basis of the MH growth trajectory (Fig. 2), we consider it likely that LM2 was less than 75 days old. Other researchers found that for some skeletal values such as humeral length or femoral length, this specimen had slightly lower values than M1 (44), so a slightly younger age for LM2 could be attributed compared to M1.

Once the M1, LM2, D1, and RdM ribcages were reconstructed, the form space PCA assessment still yielded an almost parallel growth trajectory. This is consistent with the parallel growth trajectories from other Neanderthal anatomical traits, such as the general cranium shape, clavicle length, or the femoral and tibial robusticity, features that present interspecific differences already at birth (2, 27, 45).

Our size results based on linear measurements of the ribcage show that shorter and deeper thoraces in Neanderthals are very constant throughout the early postnatal ontogeny, but absolute thorax width changes early in postnatal ontogeny. This is based on the perinatal M1 and LM2 individuals, whose ribcages are absolutely narrower than those of their MH counterparts of the same CS (M1 < MH by 0.5%, LM2 < MH by 0.3%), and on infant D1 and RdM individuals, whose ribcages are absolutely wider than those of their MH counterparts (D1 > MH by 0.5% and RdM > MH by 1.3%). The most complete individual, D1, provides us with two additional features also observed in Neanderthal adults: the relatively longer mid-thoracic ribs compared to the uppermost and lowermost ribs and the presence of a more invaginated spine within the thorax than in MH. The latter feature is also suggested by the more dorsally oriented transverse processes of the lowermost thoracic vertebrae of RdM.

Apart from the traditional measurements, the size based on CS confirms that perinatal Neanderthals already exhibited significant differences in thorax morphology when compared to MH (Figs. 1 to 4). Not only the best-preserved Neanderthal (D1) but also the rest of the individuals that were estimated using an MH reference had several features that are species-specific and distinguish them from MH: the relatively shorter thoracic spine, the deeper thorax, and the (slightly) wider ribcage, features that are also observed in adults (21, 24, 26). The relatively short thoracic spine, which is related to relatively shorter vertebral bodies, was already noticed in the D1 individual (45), and despite the limited adult Neanderthal fossil record, it has been proposed as a specific feature of the adult thoracic vertebrae (21) or the thoracic spine as a whole (26). Our results are also consistent with previous research on body form of LM2, M1 (44), and D1 (45) that hypothesized that perinatal Neanderthals already had a wide body, with a long pubis and robust long bones. Last, this is in concert with the results from the Neanderthal La Ferrassie 6, where the authors hypothesized that the elongation of the Neanderthal pubis was a feature expressed early in ontogeny (46). These features, present at birth and constant in early postnatal ontogeny, would make the trunks of very young Neanderthals volumetrically larger compared to MH, which would underline the presence of different body shapes in Neanderthals throughout their entire ontogeny (1517).

Our results support that, for the very early postnatal ontogeny (0 to 3 years), Neanderthal and MH thoraces followed an almost parallel ontogenetic trajectory, which is in agreement with research on the skull and clavicle (2, 4, 5, 27, 47). However, when looking at other anatomical regions, previous authors suggested divergent trajectories for anatomical traits such as the shape of the brain and mandible (1, 13, 14).

In our specific case, it could be argued that Neanderthals and MH followed parallel or just slightly divergent (not statistically significant) trajectories because we used an MH reference for the Neanderthal growth simulations. The inclusion of older subadult Neanderthal individuals [e.g., El Sidrn J1 (27) and Teshik-Tash 1 (48)] will complement our current understanding of their postnatal thorax growth. For the moment, our ontogenetic interpretations should be restricted to these very early stages. It is possible to find stronger morphological differences in later postnatal ontogeny of the thorax because it is a structure influenced by body composition and energy requirements, which are strongly modified during adolescence, at least in MH (49).

Together, the current evidence indicates that most of the skeletal differences between the Neanderthal and MH thorax are already largely established at birth, the Neanderthal thorax being deeper and shorter than that of MH and showing a strongly invaginated spine at a young age. This is consistent with research on the Neanderthal postcranium of M1 and LM2 that found that, with some exceptions (e.g., radius/humerus proportions), the skeletal differences between Neanderthals and MH were largely established by the time of birth. The fact that the characteristic differences between Neanderthal and MH thoracic morphologies are already present at birth indicates species-specific differences in the prenatal developmental trajectories and their genetic underpinnings. This early determination of shape might fit with paleogenetic studies proposing a selective sweep of RUNX2, a genetic fixation of genes somehow related to ribcage morphology (8).

Note that the thoracic differences between adult Neanderthals and MH were already noted by some 20th century anthropologists, who referred to adult Neanderthals as barrel-chested. However, this is confusing because the ribcages of Homo erectus from Nariokotome and the MH ribcage have also been called barrel-shaped [see references in the work by Franciscus and Churchill (22)]. Thus, while the term barrel-shaped may be useful for differentiating the thoracic bauplan of the late members of the genus Homo from that of great apes [traditionally described as having funnel-shaped ribcages (50)], it is limited when differentiating between taxa such as MH, H. erectus/ergaster, or Neanderthals. We consider the ribcage of the latter two species to be characterized by a short and deep barrel shape, whereas the MH thorax is characterized by a tall and flattened barrel shape (46), consistent with their respective somatotypes (15).

In addition, the fact that morphological differences in the ribcage are already present at birth confirms that these are relevant taxonomical characteristics that are not caused by developmental plasticity. This is consistent with the idea that the Neanderthal body plan is likely plesiomorphic in the genus Homo, inherited at least from their Middle Pleistocene ancestors from Sima de Los Huesos (11, 12, 51) if not already from H. erectus (46). Stocky bodies (high body mass index, combined with nonmodern body proportions) have been proposed for some Early Pleistocene hominins, based on the information from the Gona pelvis (52) and supported by recent estimations of Kenia National Museum-West Turkana (KNM-WT) 15,000 body size (53). Previous researchers also noticed in Neanderthal ribs and vertebrae some plesiomorphic features likely inherited from H. erectus, such as the rounder cross section, the lack of torsion of the lower ribs (22, 54, 55), and the more dorsal orientation of the transverse processes (21, 55). A recent reconstruction of the Nariokotome ribcage shows that thoracic features such as the deep and short thorax of Neanderthals are already found in H. erectus/ergaster (55). This evidence supports the hypothesis that the Neanderthal thorax, linked to a massive body, is (at least partially) inherited from their Early Pleistocene ancestors (text S6). As a consequence, the MH thorax, narrow and shallow with twisted ribs and narrow rib cross sections (12, 22, 54), would be derived within the Homo clade (text S6), suggesting that the Neanderthal ribcage morphology is a phylogenetically informative feature and not caused by developmental plasticity.

Last, the ontogenetic evidence presented here lends further support to the hypothesis that Neanderthals had high metabolic demands: Their distinctive thoracic morphology was already present at birth, and thoracic growth was faster than in MHs (10, 17, 19). Large piriform aperture/nasal bones in the RdM, LM2, D1, and D2 individuals have been observed (14, 31, 41, 56), which would be in concert with a high airflow into the respiratory system through a more projecting face in Neanderthal perinates compared to MH (14) and the hypothetical functional integration between the cranial and postcranial respiratory system (57). In addition, the morphological differences in the Neanderthal thorax found at birth, paralleling their adult state, would show a body shape characterized by shorter, deeper, and (slightly) wider trunks compared to MH of the same size. This would be consistent with previous authors on Neanderthal postcranial anatomy that proposed that perinatal individuals such as M1, LM2, or La Ferrassie 6 would be characterized by a very large ilium relative to femur length, similar to what is observed in adults (4446).

Background information regarding the Neanderthals studied here can be found in the corresponding literature (31, 36, 58, 59). Data acquisition of original thoracic material from the Neanderthals D1 and M1 was performed with helical computed tomography (CT; beam collimation, 1 mm; pitch, 1; slice reconstruction increment, 0.3 to 0.5 mm). The LM2 specimen was scanned at the Muse National de Prhistoire in Les Eyzies-de-Tayac-Sireuil using the portable industrial CT scanner (BIR ACTIS 225/300) of the Max Planck Institute for Evolutionary Anthropology Leipzig (MPI-EVA), with an isotropic voxel resolution of 70 m. The RdM Neanderthal axial skeleton was scanned with an Artec Spider 3D scanner (www.artec3d.com/). The comparative human sample comprises 29 forensic individuals whose ages comprised from birth to 3 years old that were scanned at the Institute of Forensic Medicine of the University of Zurich (text S7). All individuals were scanned in the supine position for postmortem virtual autopsy. Individuals with obvious pathologies affecting skeletal thoracic form were excluded. Because individuals were cadavers, any uncertainty caused by kinematic status while scanning was automatically ruled out. Before analysis, all CT data were anonymized to comply with the Helsinki declaration, and the approval to use these preexisting CT scans for our research was obtained from the Ethical Committee of the Canton of Zurich (BASEC-Nr. Req-2019-00987).

Ribcages were segmented through a semi-automatic protocol for Digital Imaging and Communication On Medicine (DICOM) images using the 3D Slicer software (www.slicer.org/) and subsequently reconstructed as 3D models. These 3D models were imported into Viewbox4 software (www.dhal.com) for (semi-) landmarking using existing protocols (60). Thoracic morphology was quantified through 20 homologous 3D landmarks and semilandmarks on ribs 1 to 10 and 19 3D landmarks and semilandmarks on ribs 11 and 12. Four landmarks were measured on each thoracic vertebra, and two on the sternal manubrium. The thoracic morphology was described by 524 landmarks and sliding semilandmarks (60). Semilandmarks were slid along their corresponding curves concerning the fixed landmarks to minimize bending energy from each individual to the consensus of the sample (61). Missing data in both the MH and the Neanderthals were estimated following a thin-plate spline approach (62). In the reference Neanderthal for the developmental simulations, D1, only 17% of landmarks or semilandmarks were missing, and they were estimated using MH as a reference. Once the whole set of coordinates was obtained, the landmarks were submitted to the Procrustes superimposition and analyzed following standard procedures for size and shape analysis (61). The size was studied through the CS, calculated as the square root of the sum of squared distances of all the landmarks from their centroid (61).

The TVC was used to address differences in linear measurements at different levels of the ribcage. Specifically, we studied the TVC of the 1st, 8th, and 10th ribs of the sample, because those levels were the best represented in the Neanderthal sample. Also, because the 8th and 10th levels are used for full thorax CS estimations of M1, LM2, and RdM, it is important to know whether we are under- or overestimating those sizes using costal size versus full thorax size correlations. These differences were assessed using a biplot of the log-transformed distributions of TVC versus age with the 95% confidence ellipse and the convex hull distribution for MH. In the case of the M1, LM2, and RdM Neanderthals, we plotted their estimated range of maximum and minimum age from the literature (4, 36, 37, 43). Virtual reconstruction of the thoracic elements and ribcage of the D1 subadult ribcage was done in the first place because it was the best-preserved individual of the four Neanderthals studied here. The reconstruction was done through virtual (e.g., mirror image) and statistical methods (text S1), previously validated and published (26, 63). Once the ribcage of this individual was reconstructed, we carried out forward/backward developmental simulations (64) using D1 as a reference for reconstructing the other three ribcages (LM2, M1, and RdM), based on the ontogenetic trajectory of our comparative sample of 29 recent humans from birth to 3 years (text S7).

R. A. Raff, The Shape of Life. Gene, Development, and the Evolution of Animal Form (The University of Chicago Press, 1996).

S. E. Churchill, Thin on the Ground: Neandertal Biology, Archeology and Ecology (Wiley Blackwell, 2014).

S. E. Churchill, in Neanderthals Revisited, K. Harvati, T. Harrison, Eds. (Springer Verlag, 2006), pp. 113156.

T. Akazawa, S. Muhesen, O. Kondo, Y. Dodo, The postcranial bones of the Neanderthal child burial No. 1, in Neanderthal Burials. Excavations of the Dederiyeh Cave, Afrin, Syria, T. Akazawa, S. Muhesen, Eds. (KW Publications, 2003).

J. L. Heim, Les Enfants Nandertaliens de La Ferrassie (Masson et Fondation singer Polignac, 1982).

M. Madre-Dupouy, Lenfant du Roc de Marsal. Etude analytique et comparative. Cah. Paloanthropol., 296 (1992).

C. Sasaki, K. Suzuki, H. Mishima, Y. Kozawa, Age determination of the Dederiyeh 1 Neanderthal child using enamel cross-striations, in Neanderthal Burials. Excavations of the Dederiyeh Cave, Afrin, Syria, T. Akazawa, S. Muhesen, Eds. (KW Publications, 2003).

Y. Dodo, O. Kondo, T. Nara, The skull of the Neanderthal child of burial No. 1, in Neanderthal Burials. Excavations of the Dederiyeh Cave, Afrin, Syria, T. Akazawa, S. Muhesen, Eds. (KW Publications, 2003).

Y. Dodo, O. Kondo, S. Muhesen, T. Akazawa, in Neandertals and Modern Humans in Western Asia (Springer, 2002), pp. 323338.

G. Krovitz, in Cambridge Studies in Biological and Evolutionary Anthropology (Cambridge Univ. Press, 2003), pp. 320342.

L. M. Jellema, B. Latimer, A. Walker, in The Nariokotome Homo Erectus Skeleton (Harvard Univ. Press, 1993), pp. 294325.

J. M. Carretero, J.-L. Arsuaga, I. Martinez, R. M. Quam, C. Lorenzo, A. Gracia, A. I. Ortega, in Homenaje a Emiliano Aguirre, E. Baquedano, Ed. (Museo Arqueologico Regional, 2004), vol. 4, pp. 120136.

H. Ishida, O. Kondo, in Neanderthal Burials. Excavations of the Dederiyeh Cave, Afrin, Syria, T. Akazawa, S. Muhesen, Eds. (KW Publications, 2003), pp. 271297.

D. Garca-Martnez, A. Riesco, M. Bastir, in Geometric Morphometrics: Trends in Biology, Paleobiology, and Archaeology, J. Rissech, C., Lloveras, Ll., Nadal, J., Fullola, Eds. (Universitat de Barcelona, 2018), pp. 9399.

B. Bogin, Patterns of Human Growth (Cambridge Univ. Press, ed. 2, 1999).

Acknowledgments: We acknowledge C. Cretin and P. Jacquement for providing access to the RdM individual and providing technical assistance, respectively. We also acknowledge P. Bayle for providing technical assistance with the CT scans of the LM2 axial skeleton and M. Thali (director of the Institute of Forensic Medicine of the University of Zurich) for approving access to the CT scan data. Last, we acknowledge the contribution of three anonymous reviewers and the editor that improved previous versions of this manuscript. Funding: This work was funded by the IdEx University of Bordeaux Investments for the Future program (ANR-10-IDEX-03-02); projects CGL2012-37279 and CGL2015-63648P (Spanish Ministry of Economy, Industry, and Competitiveness), CGL2015-65387-C3-2-P (MINECO/FEDER), and PGC2018-093925-B-C33 (FEDER/Ministerio de Ciencia e Innovacin-Agencia Estatal de Investigacin); and Research Group IT1044-16 from the Eusko Jaurlaritza-Gobierno Vasco and Group PPG17/05 from the Universidad del Pas Vasco-Euskal Herriko Unibertsitatea. The Juan de la Cierva Formacin program (FJCI-2017-32157), from the Spanish Ministry of Science, Innovation, and Universities, funds D.G.-M. A.G.-O. is funded by a Ramn y Cajal fellowship (RYC-2017-22558). Author contributions: Conception and design of the experiments: D.G.-M., M.B., C.P.E.Z., and M.P.d.L.; acquisition of data: D.G.-M., B.M., L.G., V.D., T.A., O.K., H.I., D.G., C.P.E.Z., and M.P.d.L.; data analysis/interpretation: D.G.-M., M.B., C.P.E.Z., M.P.d.L., A.G.-O., and Y.H.; drafting of the manuscript: D.G.-M. with the help of A.G.-O.; critical revision of the article: D.G.-M., B.M., A.G.-O., L.G., V.D., T.A., O.K., H.I., D.G., C.P.E.Z., M.P.d.L., and Y.H. Competing interests: The authors declare that they have no competing interests. Data and materials availability: All data needed to evaluate the conclusions in the paper are present in the paper and/or the Supplementary Materials. Additional data related to this paper may be requested from the authors.

More here:
Early development of the Neanderthal ribcage reveals a different body shape at birth compared to modern humans - Science Advances

ONLINE: The Future of Medicine – Isthmus

Watch here: https://www.youtube.com/watch?feature=youtu.be&v=VVkQU91KbEs

press release: The UW has a long history of pioneering medical advancements that have transformed the world. From performing the first bone marrow transplant in the United States to cultivating the first laboratory-derived human embryonic stem cells. Now, where will UW medical research go next?

On the next Wisconsin Medicine Livestream, meet trailblazing doctors, researchers, and medical leaders who are charting a bold course to completely alter the health care landscape. During this insightful panel discussion, well explore how gene therapy and cell replacements could hold the keys to treating inherited and acquired blindness. Youll also discover the remarkable potential in xenotransplantation where nonhuman animal source organs are transplanted into human recipients. In addition, you will learn about UW Healths journey to build a multidisciplinary program to serve the community. These, and other, fascinating developments in treatment and care are happening right now at the UW and are the future of medicine. The presentation will be moderated by Robert Golden, the dean of the University of WisconsinMadisons School of Medicine and Public Health.

Our Guests:

David Gamm, professor, Department of Ophthalmology and Visual Sciences; Emmett A. Humble Distinguished Director, McPherson Eye Research Institute; Sandra Lemke Trout Chair in Eye Research

Dr. Gamms lab is at the forefront in developing cell-based therapies to combat retinal degenerative diseases (RDDs). As the director of the McPherson Eye Research Institute and a member of the Waisman Center Stem Cell Research Program, the UW Stem Cell and Regenerative Medicine Center, and the American Society for Clinical Investigation, his efforts are directed toward basic and translational retinal stem cell research. The Gamm Lab uses induced pluripotent stem cells to create retinal tissues composed of authentic human photoreceptor cells rods and cones that can detect light and initiate visual signals in a dish. The aims of his laboratory are to investigate the cellular and molecular events that occur during human retinal development and to generate cells for use in retinal disease modeling and cell replacement therapies. In collaboration with other researchers at UWMadison and around the world, the lab is developing methods to produce and transplant photoreceptors and/or retinal pigment epithelium (RPE) in preparation for future clinical trials. At the same time, the Gamm Lab uses lab-grown photoreceptor and RPE cells to test and advance a host of other experimental treatments, including gene therapies. In so doing, the lab seeks to delay or reverse the effects of blinding disorders, such as retinitis pigmentosa and age-related macular degeneration, and to develop or codevelop effective interventions for these RDDs at all stages of disease.

Dhanansayan Shanmuganayagam, assistant professor, Department of Surgery, School of Medicine and Public Health; Department of Animal and Dairy Sciences, UWMadison; director, Biomedical, and Genomic Research Group

Dr. Shanmuganayagams research focuses on the development and utilization of pigs as homologous models to close the translational gap in human disease research, taking advantage of the overwhelming similarities between pigs and humans in terms of genetics, anatomy, physiology, and immunology. He and his colleagues created the human-sized Wisconsin Miniature Swine breed that is unique to the university. The breed exhibits greater physiological similarity to humans, particularly in vascular biology and in modeling metabolic disorders and obesity. He currently leads genetic engineering of swine at the UW. His team has created more than 15 genetic porcine models including several of pediatric genetic cancer-predisposition disorders such as neurofibromatosis type 1 (NF1). In the context of NF1, his lab is studying the role of alternative splicing of the nf1 gene on the tissue-specific function of neurofibromin and whether gene therapy to modulate the regulation of this splicing can be used as a viable treatment strategy for children with the disorder.

Dr. Shanmuganayagam is also currently leading the efforts to establish the University of Wisconsin Center for Biomedical Swine Research and Innovation (CBSRI) that will leverage the translatability of research in pig models and UWMadisons unique swine and biomedical research infrastructure, resources, and expertise to conduct innovative basic and translational research on human diseases. The central mission of CBSRI is to innovate and accelerate the discovery and development of clinically relevant therapies and technologies. The center will also serve to innovate graduate and medical training. As the only center of its kind in the United States, CBSRI will make UWMadison a hub of translational research and industry-partnered biomedical innovation.

Petros Anagnostopoulos, surgeon in chief, American Family Childrens Hospital; chief, Section of Pediatric Cardiothoracic Surgery; professor, Department of Surgery, Division of Cardiothoracic Surgery

Dr. Anagnostopoulos is certified by the American Board of Thoracic Surgery and the American Board of Surgery. He completed two fellowships, one in cardiothoracic surgery at the University of Pittsburgh School of Medicine and a second in pediatric cardiac surgery at the University of California, San Francisco School of Medicine. He completed his general surgery residency at Henry Ford Hospital in Detroit. Dr. Anagnostopoulos received his MD from the University of Athens Medical School, Greece. His clinical interests include pediatric congenital heart surgery and minimally invasive heart surgery.

Dr. Anagnostopoulos specializes in complex neonatal and infant cardiac reconstructive surgery, pediatric heart surgery, adult congenital cardiac surgery, single ventricle palliation, extracorporeal life support, extracorporeal membrane oxygenation, ventricular assist devices, minimally invasive cardiac surgery, hybrid surgical-catheterization cardiac surgery, off-pump cardiac surgery, complex mitral and tricuspid valve repair, aortic root surgery, tetralogy of Fallot, coronary artery anomalies, Ross operations, obstructive cardiomyopathy, and heart transplantation.

When: Tuesday, Sept. 29, at 7 p.m. CDT

Where: Wisconsin Medicine Livestream: wiscmedicine.org/programs/ending-alzheimers

Read the original here:
ONLINE: The Future of Medicine - Isthmus

Eye Tracking Market 2020 Estimated to Experience a Notable Rise in the Coming Years | Ergoneers GmbH, Eyetech Digital Systems – The Daily Chronicle

Eye Tracking Market 2020 report share informative data figures as well as important insights regarding some of the market component which is considered to be future course architects for the market. This includes factors such as market size, market share, market segmentation, significant growth drivers, market competition, different aspects impacting economic cycles in the market, demand, expected business up-downs, changing customer sentiments, key companies operating in the Eye Tracking Market, etc. In order to deliver a complete understanding of the global market, the report also shares some of the useful details regarding regional as well as significant domestic markets. The report presents a 360-degree overview and SWOT analysis of the competitive landscape of the industries.

Eye tracking is an advanced sensor technology which detects the presence, attention, and focus of the user. These details give unique insights into human behavior and facilitate natural user interface across a broad range of devices. The technology is widely being utilized in enabling hands-free interaction and creating new user experiences besides understanding human behavior. The North American region is a leading contributor in the market on account of robust adoption of smart sensors and contactless biometrics systems.

Competitive Landscape: Eye Tracking Market: Ergoneers GmbH,Eyetech Digital Systems, Inc.,ISCAN,LC Technologies, Inc. (EyeGaze),Mirametrix Inc.,Pupil Labs GmbH,Sensomotoric Instruments GmbH (Apple Inc.),Smart Eye AB,SR Research Ltd. (Eye Link),Tobii AB

Download PDF Sample Report Here:https://www.theinsightpartners.com/sample/TIPTE100000311/

Our Sample Report Accommodate a Brief Introduction of the research report, TOC, List of Tables and Figures, Competitive Landscape and Geographic Segmentation, Innovation and Future Developments Based on Research Methodology

The Global Eye Tracking Market Analysis to 2027 is a specialized and in-depth study of the technology, media and telecommunications industry with a special focus on the global market trend analysis. The report aims to provide an overview of eye tracking market with detailed market segmentation by component, type, application, industry vertical, and geography. The global eye tracking market is expected to witness high growth during the forecast period. The report provides key statistics on the market status of the leading eye tracking market players and offers key trends and opportunities in the market.

Note The Covid-19 (coronavirus) pandemic is impacting society and the overall economy across the world. The impact of this pandemic is growing day by day as well as affecting the supply chain. The COVID-19 crisis is creating uncertainty in the stock market, massive slowing of supply chain, falling business confidence, and increasing panic among the customer segments. The overall effect of the pandemic is impacting the production process of several industries. This report on Eye Tracking Market provides the analysis on impact on Covid-19 on various business segments and country markets. The reports also showcase market trends and forecast to 2027, factoring the impact of Covid -19 Situation.

The report specifically highlights the Eye Tracking market share, company profiles, regional outlook, product portfolio, a record of the recent developments, strategic analysis, key players in the market, sales, distribution chain, manufacturing, production, new market entrants as well as existing market players, advertising, brand value, popular products, demand and supply, and other important factors related to the market to help the new entrants understand the market scenario better.

In Market Segmentation by Geographical Regions, the report has analyzed the following regions-

Our reports will help clients solve the following issues:

Insecurity about the future:Our research and insights help our clients anticipate upcoming revenue compartments and growth ranges. This helps our client invest or divest their assets.

Understanding market opinions:It is extremely vital to have an impartial understanding of market opinions for a strategy. Our insights provide a keen view on the market sentiment. We keep this reconnaissance by engaging with Key Opinion Leaders of a value chain of each industry we track.

Understanding the most reliable investment centres:Our research ranks investment centers of market by considering their future demands, returns, and profit margins. Our clients can focus on most prominent investment centers by procuring our market research.

Interested in Purchasing this Report? Click here @https://www.theinsightpartners.com/buy/TIPTE100000311/

Note:If you have any special requirements, please let us know and we will offer you the report as you want.

About Us:The Insight Partners is a one stop industry research provider of actionable intelligence. We help our clients in getting solutions to their research requirements through our syndicated and consulting research services. We are a specialist in Technology, Healthcare, Manufacturing, Automotive and Defense.

Contact Us:Call: +1-646-491-9876Email:[emailprotected]

More:
Eye Tracking Market 2020 Estimated to Experience a Notable Rise in the Coming Years | Ergoneers GmbH, Eyetech Digital Systems - The Daily Chronicle

New molecular therapeutics center established at MIT’s McGovern Institute – MIT News

More than 1 million Americans are diagnosed with a chronic brain disorder each year, yet effective treatments for most complex brain disorders are inadequate or even nonexistent.

A major new research effort at the McGovern Institute for Brain Research at MIT aims to change how we treat brain disorders by developing innovative molecular tools that precisely target dysfunctional genetic, molecular, and circuit pathways.

The K. Lisa Yang and Hock E. Tan Center for Molecular Therapeutics in Neuroscience was established at MIT through a $28 million gift from philanthropist Lisa Yang and MIT alumnus Hock Tan 75. Yang is a former investment banker who has devoted much of her time to advocacy for individuals with disabilities and autism spectrum disorders. Tan is president and CEO of Broadcom, a global technology infrastructure company.This latest gift brings Yang and Tans total philanthropy to MIT to more than $72 million.

In the best MIT spirit, Lisa and Hock have always focused their generosity on insights that lead to real impact," says MIT President L. Rafael Reif. Scientifically, we stand at a moment when the tools and insights to make progress against major brain disorders are finally within reach. By accelerating the development of promising treatments, the new center opens the door to a hopeful new future for all those who suffer from these disorders and those who love them. I am deeply grateful to Lisa and Hock for making MIT the home of this pivotal research.

Engineering with precision

Research at the K. Lisa Yang and Hock E. Tan Center for Molecular Therapeutics in Neuroscience will initially focus on three major lines of investigation: genetic engineering using CRISPR tools, delivery of genetic and molecular cargo across the blood-brain barrier, and the translation of basic research into the clinical setting. The center will serve as a hub for researchers with backgrounds ranging from biological engineering and genetics to computer science and medicine.

Developing the next generation of molecular therapeutics demands collaboration among researchers with diverse backgrounds, says Robert Desimone, McGovern Institute director and the Doris and Don Berkey Professor of Neuroscience at MIT. I am confident that the multidisciplinary expertise convened by this center will revolutionize how we improve our health and fight disease in the coming decade. Although our initial focus will be on the brain and its relationship to the body, many of the new therapies could have other health applications.

There are an estimated 19,000 to 22,000 genes in the human genome and a third of those genes are active in the brain the highest proportion of genes expressed in any part of the body. Variations in genetic code have been linked to many complex brain disorders, including depression and Parkinsons disease. Emerging genetic technologies, such as the CRISPR gene editing platform pioneered by McGovern Investigator Feng Zhang, hold great potential in both targeting and fixing these errant genes. But the safe and effective delivery of this genetic cargo to the brain remains a challenge.

Researchers within the new Yang-Tan Center will improve and fine-tune CRISPR gene therapies and develop innovative ways of delivering gene therapy cargo into the brain and other organs. In addition, the center will leverage newly developed single-cell analysis technologies that are revealing cellular targets for modulating brain functions with unprecedented precision, opening the door for noninvasive neuromodulation as well as the development of medicines. The center will also focus on developing novel engineering approaches to delivering small molecules and proteins from the bloodstream into the brain. Desimone will direct the center and some of the initial research initiatives will be led by associate professor of materials science and engineering Polina Anikeeva; Ed Boyden, the Y. Eva Tan Professor in Neurotechnology at MIT; Guoping Feng, the James W. (1963) and Patricia T. Poitras Professor of Brain and Cognitive Sciences at MIT; and Feng Zhang, James and Patricia Poitras Professor of Neuroscience at MIT.

Building a research hub

My goal in creating this center is to cement the Cambridge and Boston region as the global epicenter of next-generation therapeutics research. The novel ideas I have seen undertaken at MITs McGovern Institute and Broad Institute of MIT and Harvard leave no doubt in my mind that major therapeutic breakthroughs for mental illness, neurodegenerative disease, autism, and epilepsy are just around the corner, says Yang.

Center funding will also be earmarked to create the Y. Eva Tan Fellows program, named for Tan and Yangs daughter Eva, which will support fellowships for young neuroscientists and engineers eager to design revolutionary treatments for human diseases.

We want to build a strong pipeline for tomorrows scientists and neuroengineers, explains Hock Tan. We depend on the next generation of bright young minds to help improve the lives of people suffering from chronic illnesses, and I can think of no better place to provide the very best education and training than MIT.

The molecular therapeutics center is the second research center established by Yang and Tan at MIT. In 2017, they launched the Hock E. Tan and K. Lisa Yang Center for Autism Research, and, two years later, they created a sister center at Harvard Medical School, with the unique strengths of each institution converging toward a shared goal: understanding the basic biology of autism and how genetic and environmental influences converge to give rise to the condition, then translating those insights into novel treatment approaches.

All tools developed at the molecular therapeutics center will be shared globally with academic and clinical researchers with the goal of bringing one or more novel molecular tools to human clinical trials by 2025.

We are hopeful that our centers, located in the heart of the Cambridge-Boston biotech ecosystem, will spur further innovation and fuel critical new insights to our understanding of health and disease, says Yang.

Excerpt from:
New molecular therapeutics center established at MIT's McGovern Institute - MIT News

Versus Game Announces The Launch Of First-Ever Gaming Economy – PRNewswire

SAN FRANCISCO, Sept. 8, 2020 /PRNewswire/ --Versus Game, the world's leading consumer prediction marketplace, has announced the launch of its own gaming economy through a new exclusive feature that will give players the ability to host their own games. The first of its kind, the innovation will be a unique opportunity for users to earn money and grow their own social following.

Versus Game is a mobile game dedicated to rewarding consumers for their knowledge and predictions on matchups related to celebrities, pop culture, food, business and more. The new gaming economy feature will be available exclusively in the game's Android app, and will enable players to create their own custom games using Versus Game's classic formula (i.e. Which show will be the most popular on Netflix this week?). Hosts can choose to keep the games exclusive to their inner circle or open them up for anyone in the world to play, and will earn a portion of the revenue generated from each game they create.

Currently sitting at over 3 million users, Versus Game launched last year and has given away over $8.5 million in cash prizes, with $4 million being during the current COVID era. The game has partnered with popular celebrities, brands and influencers, including Fat Joe, Foodgod and Remy Ma, and is dedicated to creating an exclusive environment for fans and talent to interact. This fall, Versus Game is planning to launch exciting collaborations with ESPN, Cumulus Media, Maxim, Lil Baby, Steve Aoki, Amanda Cerny and more.

To date, Versus Game has been a platform used by influencers and celebrities to earn money and engage with fans in a meaningful and entertaining way. With the launch of the new user-created game feature, Versus Game will open up that unique opportunity to the masses, giving anyone and everyone the chance to earn money, grow their following and build their personal brand.

"We created Versus Game because we firmly believe that knowledge should be rewarded, and with the launch of our very own gaming economy, players will have an even larger stake in their own brand," says John Vitti, Founder and CEO of Versus Game. "It's natural human behavior to make predictions surrounding culturally relevant moments, and Versus Game pays people for doing just that. The new feature will take it a step further, and give our users the ultimate opportunity to earn big, gain followers, and create compelling games. We can't wait to see what players come up with."

The new gaming economy feature will be available exclusively on Versus Game's new Android app, launching Tuesday, September 8. For more information, please visit http://www.versusgame.com.

ABOUT VERSUS GAMEVersus Game is a consumer prediction marketplace that presents timely and relevant interactive games, giving users the opportunity to get paid for being right. Players can predict the outcome of their favorite brands, celebrities, musicians, movies, athletes and more for cash prizes, with the platform being the first of its kind to bring power to the masses and allow consumers to capitalize on their knowledge of mainstream culture. To date, the platform has over 3 million users and has given away over $8.5 million in cash prizes. For more information, please visit http://www.versusgame.com.

SOURCE Versus Game

http://www.versusgame.com

Read the original here:
Versus Game Announces The Launch Of First-Ever Gaming Economy - PRNewswire

Genetic mutations may be linked to infertility, early menopause – Washington University School of Medicine in St. Louis

Visit the News Hub

Gene in fruit flies, worms, zebrafish, mice and people may help explain some fertility issues

Researchers at Washington University School of Medicine in St. Louis have identified a gene that plays an important role in fertility across multiple species. Pictured is a normal fruit fly ovary (left) and a fruit fly ovary with this gene dialed down (right). Male and female animals missing this gene had substantially defective reproductive organs. The study could have implications for understanding human infertility and early menopause.

A new study from Washington University School of Medicine in St. Louis identifies a specific genes previously unknown role in fertility. When the gene is missing in fruit flies, roundworms, zebrafish and mice, the animals are infertile or lose their fertility unusually early but appear otherwise healthy. Analyzing genetic data in people, the researchers found an association between mutations in this gene and early menopause.

The study appears Aug. 28 in the journal Science Advances.

The human gene called nuclear envelope membrane protein 1 (NEMP1) is not widely studied. In animals, mutations in the equivalent gene had been linked to impaired eye development in frogs.

The researchers who made the new discovery were not trying to study fertility at all. Rather, they were using genetic techniques to find genes involved with eye development in the early embryos of fruit flies.

We blocked some gene expression in fruit flies but found that their eyes were fine, said senior author Helen McNeill, PhD, the Larry J. Shapiro and Carol-Ann Uetake-Shapiro Professor and a BJC Investigator at the School of Medicine. So, we started trying to figure out what other problems these animals might have. They appeared healthy, but to our surprise, it turned out they were completely sterile. We found they had substantially defective reproductive organs.

Though it varied a bit by species, males and females both had fertility problems when missing this gene. And in females, the researchers found that the envelope that contains the eggs nucleus the vital compartment that holds half of an organisms chromosomes looked like a floppy balloon.

This gene is expressed throughout the body, but we didnt see this floppy balloon structure in the nuclei of any other cells, said McNeill, also a professor of developmental biology. That was a hint wed stumbled across a gene that has a specific role in fertility. We saw the impact first in flies, but we knew the proteins are shared across species. With a group of wonderful collaborators, we also knocked this gene out in worms, zebrafish and mice. Its so exciting to see that this protein that is present in many cells throughout the body has such a specific role in fertility. Its not a huge leap to suspect it has a role in people as well.

To study this floppy balloon-like nuclear envelope, the researchers used a technique called atomic force microscopy to poke a needle into the cells, first penetrating the outer membrane and then the nucleuss membrane. The amount of force required to penetrate the membranes gives scientists a measure of their stiffness. While the outer membrane was of normal stiffness, the nucleuss membrane was much softer.

Its interesting to ask whether stiffness of the nuclear envelope of the egg is also important for fertility in people, McNeill said. We know there are variants in this gene associated with early menopause. And when we studied this defect in mice, we see that their ovaries have lost the pool of egg cells that theyre born with, which determines fertility over the lifespan. So, this finding provides a potential explanation for why women with mutations in this gene might have early menopause. When you lose your stock of eggs, you go into menopause.

On the left is a normal fruit fly ovary with hundreds of developing eggs. On the right is a fruit fly ovary that is totally missing the NEMP gene. It is poorly developed and no eggs are visible.

McNeill and her colleagues suspect that the nuclear envelope has to find a balance between being pliant enough to allow the chromosomes to align as they should for reproductive purposes but stiff enough to protect them from the ovarys stressful environment. With age, ovaries develop strands of collagen with potential to create mechanical stress not present in embryonic ovaries.

If you have a softer nucleus, maybe it cant handle that environment, McNeill said. This could be the cue that triggers the death of eggs. We dont know yet, but were planning studies to address this question.

Over the course of these studies, McNeill said they found only one other problem with the mice missing this specific gene: They were anemic, meaning they lacked red blood cells.

Normal adult red blood cells lack a nucleus, McNeill said. Theres a stage when the nuclear envelope has to condense and get expelled from the young red blood cell as it develops in the bone marrow. The red blood cells in these mice arent doing this properly and die at this stage. With a floppy nuclear envelope, we think young red blood cells are not surviving in another mechanically stressful situation.

The researchers would like to investigate whether women with fertility problems have mutations in NEMP1. To help establish whether such a link is causal, they have developed human embryonic stem cells that, using CRISPR gene-editing technology, were given specific mutations in NEMP1 listed in genetic databases as associated with infertility.

We can direct these stem cells to become eggs and see what effect these mutations have on the nuclear envelope, McNeill said. Its possible there are perfectly healthy women walking around who lack the NEMP protein. If this proves to cause infertility, at the very least this knowledge could offer an explanation. If it turns out that women who lack NEMP are infertile, more research must be done before we could start asking if there are ways to fix these mutations restore NEMP, for example, or find some other way to support nuclear envelope stiffness.

This work was supported by the Canadian Institutes of Health, research grant numbers 143319, MOP-42462, PJT-148658, 153128, 156081, MOP-102546, MOP-130437, 143301, and 167279. This work also was supported, in part, by the Krembil Foundation; the Canada Research Chair program; the National Institutes of Health (NIH), grant number R01 GM100756; and NSERC Discovery grant; and the Medical Research Council, unit programme MC_UU_12015/2. Financial support also was provided by the Wellcome Senior Research Fellowship, number 095209; Core funding 092076 to the Wellcome Centre for Cell Biology; a Wellcome studentship; the Ontario Research FundsResearch Excellence Program. Proteomics work was performed at the Network Biology Collaborative Centre at the Lunenfeld-Tanenbaum Research Institute, a facility supported by Canada Foundation for Innovation funding, by the Ontarian Government, and by the Genome Canada and Ontario Genomics, grant numbers OGI-097 and OGI-139.

Tsatskis Y, et al. The NEMP family supports metazoan fertility and nuclear envelope stiffness. Science Advances. Aug. 28, 2020.

Washington University School of Medicines 1,500 faculty physicians also are the medical staff of Barnes-Jewish and St. Louis Childrens hospitals. The School of Medicine is a leader in medical research, teaching and patient care, ranking among the top 10 medical schools in the nation by U.S. News & World Report. Through its affiliations with Barnes-Jewish and St. Louis Childrens hospitals, the School of Medicine is linked to BJC HealthCare.

See more here:
Genetic mutations may be linked to infertility, early menopause - Washington University School of Medicine in St. Louis

o Aminoanisole Market 2020 Industry Growth by Jiaxing Zhonghua Chemical, WeifangUnion Biochemistry, Seya Industries Ltd, Anhui Haihua Chemical…

Courant Market Research Reports added Latest Research Report titled Global o Aminoanisole Market Status and Trend Report 2015-2025 to its research database. This report gives detailed survey of the market by examining changing aggressive elements of the o Aminoanisole Market. It helps in understanding the key product sectors and their future. It gives pin point analysis of changing rivalry flow and keeps you in front of contenders.

Request Free Sample Report of o Aminoanisole Market Report @ https://courant.biz/report/o-aminoanisole-global-market/39523/

Our Free Complimentary Sample Report Accommodate a Brief Introduction of the research report, TOC, List of Tables and Figures, Competitive Landscape and Geographic Segmentation, Innovation and Future Developments Based on Research Methodology

It offers a forward looking point of view on various elements driving or limiting business sector development. It gives a forecast based on how the market is anticipated to develop. Their key financials, general organization review, weighted SWOT examination, key advancements, developments, land spread, and procedures are contemplated and have been skillfully made in this far reaching o Aminoanisole Market report.

The o Aminoanisole Market report covers a top to bottom focused scene in which key players are profiled. Different producers engaged with the o Aminoanisole Market are surveyed. Research report for o Aminoanisole Market incorporates a worldwide viewpoint. This report investigates o Aminoanisole Market based on its market fragments, chief geologies, and current market patterns. This can bolster the user in settling on educated choices and major key systems.

Download Free PDF Report Brochure @ https://courant.biz/report/o-aminoanisole-global-market/39523/

Note In order to provide more accurate market forecast, all our reports will be updated before delivery by considering the impact of COVID-19.

This can bolster the user in settling on educated choices and major key systems. The beat of the market is unveiled in this sector which can enable the user in applying key strategies to attain competitive benefit. Such a top to bottom, far reaching research survey conveys the genuinely necessary esteem expansion, with unbiased measurable analysis and key suggestions, which can be utilized to design future extensions and enhance current position in the o Aminoanisole Market in a specific area.

Imperative areas all over the globe are secured and the patterns, advancements, drivers, restrictions, and difficulties affecting the development of the o Aminoanisole Market over these vital regions are considered. An evaluation of the effect of government strategies and holistic on the market processes is likewise included to give an all encompassing outline of the o Aminoanisole Market future viewpoint.

Inquire more about this report @ https://courant.biz/report/o-aminoanisole-global-market/39523/

Browse Full Report @ https://courant.biz/report/o-aminoanisole-global-market/39523/

Customization of the Report:This report can be customized to meet the clients requirements. Please connect with our sales team ([emailprotected]), who will ensure that you get a report that suits your needs.

Originally posted here:
o Aminoanisole Market 2020 Industry Growth by Jiaxing Zhonghua Chemical, WeifangUnion Biochemistry, Seya Industries Ltd, Anhui Haihua Chemical...